(Q3)Sep 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||
Cash flow from continuing operating activities | -36.71%1.22M | 928.46%5.35M | 238.37%8.91M | 6.13M | 1.93M | 520K | 238.67%2.63M | -1.9M |
Net income from continuing operations | 88.10%-1.42M | 816.62%2.5M | -73.92%-8.62M | --1.91M | ---11.95M | ---349K | 1.25%-4.96M | ---5.02M |
Operating gains losses | 111.11%13K | -566.67%-14K | 123.06%95K | --267K | ---117K | --3K | -1,616.67%-412K | ---24K |
Depreciation and amortization | -56.92%766K | -52.88%810K | -19.13%6.22M | --696K | --1.78M | --1.72M | -7.78%7.69M | --8.34M |
Asset impairment expenditure | --0 | ---- | --15.2M | --0 | --15.2M | ---- | --0 | --0 |
Deferred tax | --0 | --0 | -51.16%-2.87M | --0 | ---2.55M | ---325K | -17.00%-1.9M | ---1.62M |
Other non cashItems | -80.00%12K | 112.50%17K | 185.23%251K | --59K | --60K | --8K | 1,000.00%88K | --8K |
Change In working capital | 468.33%1.85M | 479.48%2.03M | -164.48%-1.37M | --3.2M | ---502K | ---536K | 159.22%2.12M | ---3.58M |
-Change in receivables | 284.68%2.52M | 494.44%355K | -286.94%-4.59M | --3.33M | ---1.36M | ---90K | 143.87%2.46M | ---5.6M |
-Change in inventory | 85.77%-347K | 216.06%643K | -260.73%-352K | ---518K | ---2.44M | ---554K | 155.44%219K | ---395K |
-Change in payables and accrued expense | -109.79%-323K | 859.26%1.04M | 551.43%4.12M | --933K | --3.3M | --108K | -130.84%-912K | --2.96M |
-Change in other working capital | ---- | ---- | -251.40%-539K | ---- | ---- | ---- | 165.80%356K | ---541K |
Cash from discontinued investing activities | ||||||||
Operating cash flow | -36.71%1.22M | 928.46%5.35M | 238.37%8.91M | --6.13M | --1.93M | --520K | 238.67%2.63M | ---1.9M |
Investing cash flow | ||||||||
Cash flow from continuing investing activities | 88.17%-57K | -1,566.67%-550K | -433.33%-1.08M | -93K | -482K | -33K | 117.75%324K | -1.83M |
Capital expenditure reported | 88.17%-57K | -1,566.67%-550K | -169.33%-1.08M | ---93K | ---482K | ---33K | 78.56%-401K | ---1.87M |
Net PPE purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | 1,511.11%725K | --45K |
Cash from discontinued investing activities | ||||||||
Investing cash flow | 88.17%-57K | -1,566.67%-550K | -433.33%-1.08M | ---93K | ---482K | ---33K | 117.75%324K | ---1.83M |
Financing cash flow | ||||||||
Cash flow from continuing financing activities | -2,780.90%-5.13M | -69.86%-124K | 28.10%-714K | -179K | -178K | -73K | 80.01%-993K | -4.97M |
Net issuance payments of debt | 28.09%-128K | -69.86%-124K | -193.83%-714K | ---179K | ---178K | ---73K | 16.78%-243K | ---292K |
Cash dividends paid | ---5M | ---- | --0 | --0 | --0 | ---- | 83.96%-750K | ---4.68M |
Cash from discontinued financing activities | ||||||||
Financing cash flow | -2,780.90%-5.13M | -69.86%-124K | 28.10%-714K | ---179K | ---178K | ---73K | 80.01%-993K | ---4.97M |
Net cash flow | ||||||||
Beginning cash position | 391.10%18.82M | 184.92%10.96M | 103.92%3.85M | --5.1M | --3.83M | --3.85M | -82.15%1.89M | --10.56M |
Current changes in cash | -413.27%-3.97M | 1,028.99%4.67M | 262.30%7.11M | --5.86M | --1.27M | --414K | 122.59%1.96M | ---8.69M |
Effect of exchange rate changes | --0 | --0 | --0 | --0 | --0 | --0 | -125.00%-3K | --12K |
End cash Position | 191.39%14.86M | 266.95%15.63M | 184.92%10.96M | --10.96M | --5.1M | --4.26M | 103.92%3.85M | --1.89M |
Free cash from | -19.53%1.16M | 885.22%4.8M | 250.78%7.83M | --6.04M | --1.44M | --487K | 159.21%2.23M | ---3.77M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data